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Staged Endovascular Repair of Thoracoabdominal
Aneurysms (TAA) Protects Against Spinal Cord injury
Adrian O’Callaghan1, Matthew J. Eagleton1, Tara M.
Mastracci1, James Bena2. 1Vascular Surgery, Cleveland
Clinic, Cleveland, Ohio; 2Department of Quantitative
Health Sciences, Cleveland Clinic, Cleveland, Ohio
Objectives: Spinal cord ischemia (SCI) devastatingly
complicates extensive aortic repair owing to disruption of
spinal perfusion. We hypothesized that staged repair might
provide time for collateral development and lessen the surgi-
cal insult, thus mitigating the incidence and severity of SCI.
Methods: We conducted a retrospective cohort study
of patients undergoing endovascular type II thoracoabdo-
minal aortic aneurysm (TAAA) repair. Staged repair was
deﬁned as intentional completion of the endovascular
repair as two temporally separate procedures. Extent of
aortic cover was calculated using three-dimensional imag-
ing. Primary outcome measures were the incidence and
severity of SCI and mortality.
Results: Ninety-one patients underwent type II repair
between January 2008 and July 2013. Thirty-four patients
with prior aortic surgery were excluded. Thirty-two non-
staged repairs (NSR) and 27 staged repairs (SR) repairs
were performed. Both groups were equivalent in demo-
graphics and risk factors. A signiﬁcantly greater percentage
of the aorta was covered in the SR group (94% vs 86%, P ¼
.001). Median time to the second-stage repair was 4
months (range, 1-60 months). Rates of SCI were 37.5%
(NSR) and 11.1% (SR; P ¼ .03). All neurologic injuries
in SR were temporary, but resolved in only 58% of the
NSR group. The 30-day mortality rates were 18.8%
(NSR) and 0% (SR), and these differences persisted during
follow-up (P ¼ .03; Fig).Fig. Survival, staged vs nonstaged repair.Conclusions: Primary staged repair is protective
against SCI development and severity. In addition, the
staged approach lowers 30-day and long-term mortality.
Further investigations will be directed towards understand-
ing the physiology of this beneﬁt
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3D Fusion Overlay Imaging Is an Important Adjunct
for Reducing Radiation Dose, Contrast Volume, and
Surgery Time when Performing Fenestrated
Endovascular Aneurysm Repair
Andres Schanzer, Manuela Schuksz. University of
Massachusetts Medical School, Worcester, Mass
Objectives: Fenestrated endovascular aneurysm repair
is now a Food andDrug Administration-approved treatment
in the United States for short-neck infrarenal aortic aneu-
rysms and for juxtarenal aortic aneurysms. These complex
endovascular aortic aneurysm repairs necessitate larger doses
of radiation, increased volumes of contrast, and increased
operative time. This video provides a step-by-step description
ofhowthree-dimensional (3D) fusionoverlay imagingcanbe
used to reduce radiation dose, contrast volume, and surgery
time during fenestrated endovascular aortic aneurysm repair.
Technical description: An 85-year-old man presented
for a commercially available fenestrated endovascular repair
of a 6.1-cm abdominal aortic aneurysm with a 4-mm
infrarenal neck. Since August 2013, all endovascular aortic
aneurysm repairs performed at the University of Massachu-
setts Medical School use 3D fusion imaging. The patient
underwent successful percutaneous fenestrated endovascu-
lar repair of his aortic aneurysm with complete exclusion of
the aneurysm and preservation of branch artery circulation
with stent grafted bilateral renal artery fenestrations and an
unstented scallop for the superior mesenteric artery. The
total radiation dose administered was 987 gy, total contrast
use was 18 mL, and total operative time was 111 minutes.
With the recent approval of a fenestrated endovascular de-
vice in the United States, and with several more devices in
the pipeline, the number of complex endovascular aortic
aneurysm repairs will continue to increase. These complex
procedures generally require increased radiation dose,
contrast volume, and operative time. The use of 3D fusion
overlay imaging is an important modality to reduce radia-
tion dose, contrast volume, and surgery time during endo-
vascular aortic aneurysm repair.
Author Disclosures: A. Schanzer: Cook Medical and
Bolton Medical, consulting fees or other remuneration
(payment); M. Schuksz: Nothing to disclose.
SS3.
Factors Associated With Spinal Cord Ischemia After
Multibranched Endovascular Thoracoabdominal
Aneurysm Repair
Julia D. Sobel1, Shant M. Vartanian1, Warren J. Gasper1,
Marlene Grenon2, Joseph H. Rapp2, Jade S. Hiramoto1,
Timothy A. Chuter1, Linda M. Reilly1. 1Division of
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 6S Abstracts 23SVascular and Endovascular Surgery, University of
California, San Francisco, San Francisco, Calif; 2San
Francisco VA Medical Center, San Francisco, Calif
Objectives: Spinal cord ischemia (SCI) after open or
endovascular thoracoabdominal aortic aneurysm (TAAA)
repairs is a serious complication with adverse effects on
quality of life and long-term survival. Many risk factors
for SCI after open surgery have been identiﬁed; however,
the pathophysiology of SCI after endovascular repair is
less understood. Our aim was to identify factors associated
with postoperative SCI after multibranched endovascular
aneurysm repair (MBEVAR) for TAAA.
Methods: From July 2005 to October 2013, 116 pa-
tients with TAAA (30 women; mean age, 73.46 7.7 years)
were treated in a prospective, single-center trial for MBE-
VAR. Symptomatic patients and those with dissection
were excluded. SCI was classiﬁed into lower extremity pa-
ralysis (LEP), permanent lower extremity weakness
(pLEW), and transient LEW (tLEW). Perioperative spinal
cord protection measures included cerebrospinal ﬂuid
(CSF) drainage and permissive hypertension.
Results: Postoperative SCI occurred in 24 of 116 pa-
tients (20.6%). Most patients had tLEW (15 of 116
[12.9%]) with full recovery, and less frequently pLEW (n
¼ 3 of 116 [2.6%]) or LEP (n ¼ 6 of 116, 5.2%). Onset
of 79% of SCI events (19 of 24) was delayed (>6 h post-
operative), were transient in 62.5% (15 of 24), and symp-
toms resolved within a median of 1 day (interquartile
range, 1-3.5 days). Prolonged postoperative hypotension
was associated with SCI (odds ratio, 5.0; 95% conﬁdence
interval, 1.6-16.1; P < .01). Aneurysm extent or the pres-
ence of a postoperative endoleak was not associated with
SCI events. The change in C-reactive protein levels from
baseline to peak was 1.8-times greater in patients with
SCI than those without (P ¼ .03).
Conclusions: Most episodes of SCI after MBEVAR
are transient and do not occur in the operating room.
Increased systemic inﬂammation may have an adverse effect
on spinal cord perfusion and play a role in the delayed onset
of SCI. Current adjunct strategies to maintain spinal cord
perfusion, including permissive hypertension and CSF
drainage, may help prevent permanent SCI.
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In Patients Stratiﬁed by Preoperative Risk,
Endovascular Repair of Ruptured Abdominal Aortic
Aneurysms Has a Lower In-Hospital Mortality and
Morbidity Than Does Open Repair
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Objectives: Endovascular repair (EVAR) of ruptured
abdominal aortic aneurysms (RAAA) is reported to have a
lower postoperative mortality than open repair (OR).
However, comparisons have involved heterogeneous
populations that lack adjustment for preoperative risk.
We hypothesize that for RAAA patients stratiﬁed by
a validated measure of preoperative mortality risk,
EVAR has a lower in-hospital mortality and morbidity
than does OR.
Methods: In-hospital mortality and morbidity after
EVAR and OR of RAAA were compared in patients from
the Vascular Quality Initiative (2003-2013) stratiﬁed by
the validated Vascular Study Group of New England
(VSGNE) RAAA Risk Score into low (score 0-1), moder-
ate (score 2-3), and high (score 4-6) risk groups.
Results: Among 592 patients who underwent EVAR
and 703 patients who underwent OR of RAAA, EVAR
had lower in-hospital mortality (23% vs 36%, P < .001).
In risk-stratiﬁed patients, EVAR trended towards a lower
mortality in the low risk group (n ¼ 631; EVAR 11% vs
OR 16%; P ¼ .07), had a signiﬁcantly lower mortality in
the moderate risk group (n ¼ 460; EVAR 37% vs OR
48%; P ¼ .02), and no advantage in the high risk group
(n ¼ 84; EVAR 95% vs OR 80%; P ¼ .17). Across all
risk groups, cardiac complications (EVAR: 28% vs OR:
38%; P ¼ .0003), respiratory complications (EVAR: 27%
vs OR: 46%; P < .0001), renal insufﬁciency (EVAR: 23%
vs OR: 37%; P < .0001), and bowel ischemia (EVAR: 4%
vs OR: 10%; P < .0001) were reduced signiﬁcantly after
EVAR. Across all risk groups, intensive care unit length
of stay (LOS) for EVAR (2 days; interquartile range
[IQR], 1-5 days) vs OR (6 days; IQR, 4-13 days; P <
.0001) and hospital LOS for EVAR (5 days; IQR, 3-11
days) vs OR (13 days; IQR, 8-22 days; P < .0001) were
lower after EVAR than OR.
Conclusions: This ﬁrst risk-stratiﬁed comparison us-
ing a national clinical database shows that EVAR of
RAAA has a lower mortality and morbidity compared
with OR in patients of low and moderate risk, and EVAR
should be used to treat these patients when feasible. For
RAAA patients at highest preoperative risk, there is no
beneﬁt to using EVAR compared with OR.
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